#dr reddy's
Related Stories (5)
Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine - reuters.com
Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine reuters.com
September 18, 2026Indian shares extend drop on oil surge; Dr Reddy's falls on subdued earnings - Reuters
Indian shares extend drop on oil surge; Dr Reddy's falls on subdued earnings Reuters
July 23, 2026India's Dr Reddy's warns of wider semaglutide supply impact after profit miss - Reuters
India's Dr Reddy's warns of wider semaglutide supply impact after profit miss Reuters
July 22, 2026India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value - Reuters
India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value Reuters
July 9, 2026Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say - Reuters
Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say Reuters
February 25, 2026Related Pages (7)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Dr Reddy's files 'Obeda' trademark ahead of generic ozempic launch
Hyderabad-based Dr Reddy’s Laboratories has applied to trademark the brand name and logo “Obeda”, according to sources. The proposed brand is expected to be the company’s version of semaglutide, the
Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say
Listen to this article in summarized format Unlock AI Briefing and Premium Content (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Econo
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa